| RS121913588 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913589 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913590 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913593 |
MPZ
|
Health Risk |
Pathogenic |
Neuropathy, congenital hypomyelinating |
| RS121913594 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913595 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B |
| RS121913596 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate D, Charcot-Marie-Tooth disease |
| RS121913597 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 1B |
| RS121913598 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B |
| RS121913599 |
MPZ
|
Health Risk |
Pathogenic |
Roussy-Lévy syndrome, Charcot-Marie-Tooth disease type 1B |
| RS121913600 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913601 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B |
| RS121913602 |
MPZ
|
Health Risk |
Pathogenic |
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1B |
| RS121913603 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913604 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 1B |
| RS121913605 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease |
| RS121913608 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913609 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease |
| RS121913610 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Congenital amegakaryocytic thrombocytopenia 1 |
| RS121913611 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS121913612 |
MPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS121913613 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia 1, Congenital amegakaryocytic thrombocytopenia 1 |
| RS121913614 |
MPL
|
Health Risk |
Pathogenic |
Thrombocythemia 2, Congenital amegakaryocytic thrombocytopenia |
| RS121913615 |
MPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Myelofibrosis with myeloid metaplasia, Thrombocythemia 2 |
| RS121913616 |
MPL
|
Health Risk |
Pathogenic |
Myelofibrosis with myeloid metaplasia, Myelofibrosis with myeloid metaplasia |
| RS121913617 |
MYH3
|
Health Risk |
Pathogenic |
Freeman-Sheldon syndrome, Contractures |
| RS121913618 |
MYH3
|
Health Risk |
Pathogenic |
Freeman-Sheldon syndrome, Freeman-Sheldon syndrome |
| RS121913619 |
MYH3
|
Health Risk |
Pathogenic |
Freeman-Sheldon syndrome, Arthrogryposis |
| RS121913620 |
MYH3
|
Health Risk |
Pathogenic |
Freeman-Sheldon syndrome, Freeman-Sheldon syndrome |
| RS121913621 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, distal |
| RS121913623 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, distal |
| RS121913624 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Primary familial hypertrophic cardiomyopathy |
| RS121913625 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Primary familial hypertrophic cardiomyopathy |
| RS121913626 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913627 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Primary familial hypertrophic cardiomyopathy |
| RS121913628 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913629 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Cardiomyopathy |
| RS121913630 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Primary familial hypertrophic cardiomyopathy |
| RS121913631 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Primary familial hypertrophic cardiomyopathy |
| RS121913632 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913633 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913634 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913636 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 1 |
| RS121913637 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Cardiovascular phenotype |
| RS121913638 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913639 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913641 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 1, Cardiovascular phenotype |
| RS121913642 |
MYH7
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1S, Primary dilated cardiomyopathy |
| RS121913643 |
MYH7
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1S, Hypertrophic cardiomyopathy |
| RS121913644 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS121913647 |
MYH7
|
Health Risk |
Pathogenic |
MYH7-related skeletal myopathy, Hypertrophic cardiomyopathy |
| RS121913648 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
MYH7-related skeletal myopathy, Hypertrophic cardiomyopathy |
| RS121913649 |
MYH7
|
Health Risk |
Pathogenic |
Myosin storage myopathy, Myosin storage myopathy |
| RS121913650 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913651 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS121913654 |
MYH7
|
Health Risk |
Pathogenic/Likely pathogenic |
Left ventricular noncompaction 5, Hypertrophic cardiomyopathy 1 |
| RS121913655 |
MYH9
|
Health Risk |
Pathogenic/Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, MYH9-related disorder |
| RS121913656 |
MYH9
|
Health Risk |
Pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS121913657 |
MYH9
|
Health Risk |
Pathogenic/Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Autosomal dominant nonsyndromic hearing loss 17 |
| RS121913659 |
NDUFV1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 4 |
| RS121913660 |
NDUFV1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 4 |
| RS121913661 |
NDUFV1
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 4 |
| RS121913662 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy |
| RS121913663 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1F, Charcot-Marie-Tooth disease type 1F |
| RS121913664 |
NFKBIA
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia and immunodeficiency 2, Inherited Immunodeficiency Diseases |
| RS121913665 |
NFKBIA
|
Health Risk |
Pathogenic |
Ectodermal dysplasia and immunodeficiency 2, Ectodermal dysplasia and immunodeficiency 2 |
| RS121913667 |
MYCN
|
Health Risk |
Pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS121913668 |
MET
|
Health Risk |
Pathogenic/Likely pathogenic |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS121913669 |
MET
|
Health Risk |
Pathogenic |
Papillary renal cell carcinoma type 1, Papillary renal cell carcinoma type 1 |
| RS121913670 |
MET
|
Health Risk |
Pathogenic/Likely pathogenic |
Papillary renal cell carcinoma type 1, Hereditary cancer-predisposing syndrome |
| RS121913671 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Papillary renal cell carcinoma type 1, Embryonal rhabdomyosarcoma |
| RS121913676 |
MET
|
Health Risk |
Pathogenic |
Pediatric hepatocellular carcinoma, Pediatric hepatocellular carcinoma |
| RS121913677 |
MET
|
Health Risk |
Pathogenic |
Pediatric hepatocellular carcinoma, Pediatric hepatocellular carcinoma |
| RS121913678 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS121913679 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Piebaldism |
| RS121913680 |
KIT
|
Health Risk |
Likely pathogenic |
Piebaldism, Gastrointestinal stromal tumor |
| RS121913684 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism with sensorineural deafness, Piebaldism with sensorineural deafness |
| RS121913685 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS121913687 |
KIT
|
Health Risk |
Pathogenic |
Piebaldism, Piebaldism |
| RS1219150462 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1219155526 |
FREM2
|
Health Risk |
Likely pathogenic |
FREM2-related disorder, Fraser syndrome 2 |
| RS1219156713 |
DICER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, DICER1-related tumor predisposition |
| RS1219162630 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1219173005 |
AKT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome 6, Cowden syndrome 6 |
| RS121917703 |
FGF3
|
Health Risk |
Pathogenic |
Deafness with labyrinthine aplasia, microtia |
| RS121917704 |
FGF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness with labyrinthine aplasia, microtia |
| RS121917705 |
FGF3
|
Health Risk |
Likely pathogenic |
Deafness with labyrinthine aplasia, microtia |
| RS121917706 |
FGF3
|
Health Risk |
Pathogenic |
Deafness with labyrinthine aplasia, microtia |
| RS121917707 |
GLI2
|
Health Risk |
Pathogenic |
Holoprosencephaly 9, Holoprosencephaly 9 |
| RS121917708 |
GLI2
|
Health Risk |
Pathogenic |
Holoprosencephaly 9, Holoprosencephaly 9 |
| RS121917709 |
GLI3
|
Health Risk |
Pathogenic |
Postaxial polydactyly, type A1/B |
| RS121917711 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS121917712 |
GLI3
|
Health Risk |
Pathogenic/Likely pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS121917713 |
GLI3
|
Health Risk |
Pathogenic |
Polysyndactyly 4, Greig cephalopolysyndactyly syndrome |
| RS121917714 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS121917715 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS121917716 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Hirschsprung disease |
| RS121917719 |
PAX8
|
Health Risk |
Pathogenic |
Hypothyroidism, congenital |
| RS121917720 |
PAX9
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS121917721 |
PEPD
|
Health Risk |
Pathogenic |
Prolidase deficiency, Prolidase deficiency |